Serial block-face scanning electron microscopy applied to study the trafficking of 8D3-coated gold nanoparticles at the blood–brain barrier

Due to the physical and physiological properties of the blood–brain barrier (BBB), the transport of neurotherapeutics from blood to brain is still a pharmaceutical challenge. We previously conducted a series of experiments to explore the potential of the anti-transferrin receptor 8D3 monoclonal antibody (mAb) to transport neurotherapeutics across the BBB. In that study, gold nanoparticles (AuNPs) were coated with the 8D3 antibody and administered intravenously to mice. Transmission electron microscopy was used and a two-dimensional (2D) image analysis was performed to detect the AuNPs in the brain capillary endothelial cells (BCECs) and brain parenchyma. In the present work, we determined that serial block-face scanning electron microscopy (SBF-SEM) is a useful tool to study the transcytosis of these AuNPs across the BBB in three dimensions and we, therefore, applied it to gain more knowledge of their transcellular trafficking. The resulting 3D reconstructions provided additional information on the endocytic vesicles containing AuNPs and the endosomal processing that occurs inside BCECs. The passage from 2D to 3D analysis reinforced the trafficking model proposed in the 2D study, and revealed that the vesicles containing AuNPs are significantly larger and more complex than described in our 2D study. We also discuss tradeoffs of using this technique for our application, and conclude that together with other volume electron microscopy imaging techniques, SBF-SEM is a powerful approach that is worth of considering for studies of drug transport across the BBB.

[1]  C. Peddie,et al.  Exploring the third dimension: volume electron microscopy comes of age. , 2014, Micron.

[2]  T. Deerinck,et al.  NCMIR methods for 3D EM: a new protocol for preparation of biological specimens for serial block face scanning electron microscopy , 2010 .

[3]  E. Morgan,et al.  Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat , 2001, Journal of neurochemistry.

[4]  F. Calon,et al.  In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin Receptor , 2011, Molecular Pharmacology.

[5]  W. Pardridge,et al.  Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.

[6]  F. Calon,et al.  Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. , 2003, Human gene therapy.

[7]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[8]  P. Freskgård,et al.  Antibody therapies in CNS diseases , 2017, Neuropharmacology.

[9]  Davi D Bock,et al.  Volume electron microscopy for neuronal circuit reconstruction , 2012, Current Opinion in Neurobiology.

[10]  J. del Valle,et al.  Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  G. Storm,et al.  Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  Drug targeting to the brain. , 2007, Annual review of pharmacology and toxicology.

[13]  B. Asselbergh,et al.  Developing 3D SEM in a broad biological context , 2015, Journal of microscopy.

[14]  E. Shusta,et al.  Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. , 2015, Annual review of pharmacology and toxicology.

[15]  W. Pardridge,et al.  CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport , 1998, Journal of neurochemistry.

[16]  Satoshi Shimo,et al.  Conductive resins improve charging and resolution of acquired images in electron microscopic volume imaging , 2016, Scientific Reports.

[17]  B. Engelhardt,et al.  Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.

[18]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[19]  S. Saitoh,et al.  Three-dimensional volume imaging with electron microscopy toward connectome. , 2015, Microscopy.

[20]  A. Rees,et al.  Vector-mediated drug delivery to the brain , 2001, Expert opinion on biological therapy.

[21]  F. Calon,et al.  Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion. , 2014, Molecular pharmaceutics.

[22]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[23]  A. Camins,et al.  Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier. , 2015, Molecular pharmaceutics.